Anti-PFKP antibody (336-540 aa) [SRM] (STJ11107271)

SKU:
STJ11107271

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Monoclonal
Clone ID: SRM
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.09% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:1000-1:4000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: PFKP
Gene ID: 5214
Uniprot ID: PFKAP_HUMAN
Immunogen Region: 336-540 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 336-540 of human PFKP (NP_002618.1).
Immunogen Sequence: ATPDTPACVVSLNGNHAVRL PLMECVQMTQDVQKAMDERR FQDAVRLRGRSFAGNLNTYK RLAIKLPDDQIPKTNCNVAV INVGAPAAGMNAAVRSAVRV GIADGHRMLAIYDGFDGFAK GQIKEIGWTDVGGWTGQGGS ILGTKRVLPGKYLEEIATQM RTHSINALLIIGGFEAYLGL LELSAAREKHEEFCVPMVMV PATVS
Post Translational Modifications Phosphorylation at Ser-386 promotes interaction with ATG4B. GlcNAcylation decreases enzyme activity.
Function Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis.
Protein Name Atp-Dependent 6-Phosphofructokinase - Platelet Type
Atp-Pfk
Pfk-P
6-Phosphofructokinase Type C
Phosphofructo-1-Kinase Isozyme C
Pfk-C
Phosphohexokinase
Database Links Reactome: R-HSA-70171
Cellular Localisation Cytoplasm
Alternative Antibody Names Anti-Atp-Dependent 6-Phosphofructokinase - Platelet Type antibody
Anti-Atp-Pfk antibody
Anti-Pfk-P antibody
Anti-6-Phosphofructokinase Type C antibody
Anti-Phosphofructo-1-Kinase Isozyme C antibody
Anti-Pfk-C antibody
Anti-Phosphohexokinase antibody
Anti-PFKP antibody
Anti-PFKF antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance